← All trials
NCT04458389
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 7, 2020
- Primary completion
- Jun 30, 2024
- Completion date
- Jul 31, 2025
- First posted
- Jul 7, 2020
- Last posted
- Dec 30, 2020
- Enrollment
- 268
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Tayu Huaxia Biotech Medical Group Co., Ltd.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.